PortfoliosLab logoPortfoliosLab logo
Certara, Inc. (CERT)
Performance
Return for Risk
Dividends
Drawdowns
Volatility
Financials

Company Info

ISIN
US15687V1098
CUSIP
15687V109
IPO Date
Dec 11, 2020

Highlights

Market Cap
$914.25M
Enterprise Value
$739.22M
EPS (TTM)
-$0.01
Total Revenue (TTM)
$418.84M
Gross Profit (TTM)
$257.71M
EBITDA (TTM)
$44.43M
Year Range
$5.60 - $15.38
Target Price
$12.00
ROA (TTM)
-0.10%
ROE (TTM)
-0.15%

Share Price Chart


Loading graphics...

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Certara, Inc.

Performance

Performance Chart

The chart shows the growth of an initial investment of $10,000 in Certara, Inc., comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.


Loading graphics...

S&P 500 Index

Returns By Period

Certara, Inc. (CERT) has returned -35.30% so far this year and -42.42% over the past 12 months.


Certara, Inc.

1D
0.35%
1M
-19.49%
YTD
-35.30%
6M
-53.36%
1Y
-42.42%
3Y*
-38.17%
5Y*
-26.98%
10Y*

Benchmark (S&P 500 Index)

1D
2.91%
1M
-5.09%
YTD
-4.63%
6M
-2.39%
1Y
16.33%
3Y*
16.69%
5Y*
10.18%
10Y*
12.16%
*Multi-year figures are annualized to reflect compound growth (CAGR)

Monthly Returns

Based on dividend-adjusted daily data since Dec 11, 2020, CERT's average daily return is -0.08%, while the average monthly return is -1.60%.

Historically, 41% of months were positive and 59% were negative. The best month was Apr 2025 with a return of +40.0%, while the worst month was Nov 2021 at -34.8%. The longest winning streak lasted 3 consecutive months, and the longest losing streak was 6 months.

On a daily basis, CERT closed higher 49% of trading days. The best single day was Apr 11, 2025 with a return of +22.8%, while the worst single day was Nov 7, 2025 at -23.1%.


JanFebMarAprMayJunJulAugSepOctNovDecTotal
2026-0.23%-19.45%-19.49%-35.30%
202533.62%-15.81%-17.36%40.00%-18.04%2.99%-15.90%10.16%12.73%-4.83%-21.24%-3.82%-17.28%
2024-8.13%4.46%5.92%-4.31%-0.94%-18.29%12.71%-21.52%-4.41%-12.89%9.90%-5.00%-39.45%
202320.72%-6.60%33.06%0.25%-14.03%-12.37%6.92%-17.00%-10.02%-16.16%18.21%22.07%9.46%
2022-5.95%-5.20%-15.23%-14.57%10.74%5.61%7.13%-31.84%-15.25%-7.91%38.84%-5.36%-43.46%
20212.08%0.67%-21.21%16.52%-17.29%7.68%-3.95%23.37%-1.40%24.80%-34.81%5.53%-15.72%

Benchmark Metrics

Certara, Inc. has an annualized alpha of -30.27%, beta of 1.26, and R² of 0.14 versus S&P 500 Index. Calculated based on daily prices since December 14, 2020.

  • This stock participated in 199.57% of S&P 500 Index downside but only 37.08% of its upside — more exposed to losses than it benefited from rallies.
  • R² of 0.14 means this stock moves largely independently of S&P 500 Index — capture ratios reflect limited market correlation rather than active downside protection. Consider using a more representative benchmark.

Alpha
-30.27%
Beta
1.26
0.14
Upside Capture
37.08%
Downside Capture
199.57%

Return for Risk

Risk / Return Rank

CERT ranks 13 for risk / return — in the bottom 13% of stocks on our site. This means you're taking on significantly more risk than the returns justify. Consider whether the potential upside is worth the volatility, or explore alternatives with better risk / return profiles.


CERT Risk / Return Rank: 1313
Overall Rank
CERT Sharpe Ratio Rank: 1111
Sharpe Ratio Rank
CERT Sortino Ratio Rank: 1212
Sortino Ratio Rank
CERT Omega Ratio Rank: 1313
Omega Ratio Rank
CERT Calmar Ratio Rank: 1616
Calmar Ratio Rank
CERT Martin Ratio Rank: 1414
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

Return / Risk — by metrics

The table below present risk-adjusted performance metrics for Certara, Inc. (CERT) and compare them to a chosen benchmark (S&P 500 Index).


CERTBenchmarkDifference

Sharpe ratio

Return per unit of total volatility

-0.70

0.90

-1.59

Sortino ratio

Return per unit of downside risk

-0.88

1.39

-2.26

Omega ratio

Gain probability vs. loss probability

0.89

1.21

-0.32

Calmar ratio

Return relative to maximum drawdown

-0.70

1.40

-2.10

Martin ratio

Return relative to average drawdown

-1.32

6.61

-7.92

Explore CERT risk-adjusted metrics in detail

Dive deeper into individual metrics with historical trends, benchmark comparisons, and performance across different time periods.

Dividends

Dividend History


Certara, Inc. doesn't pay dividends

Drawdowns

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.


Loading graphics...

Worst Drawdowns

The table below displays the maximum drawdowns of the Certara, Inc.. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the Certara, Inc. was 87.44%, occurring on Mar 30, 2026. The portfolio has not yet recovered.

The current Certara, Inc. drawdown is 87.39%.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-87.44%Nov 5, 20211102Mar 30, 2026
-39.12%Dec 24, 2020139Jul 15, 202174Oct 28, 2021213
-11.79%Dec 14, 20201Dec 14, 20202Dec 16, 20203
-9.43%Dec 18, 20201Dec 18, 20203Dec 23, 20204

Volatility

Volatility Chart

The chart below shows the rolling one-month volatility.


Loading graphics...

Financials

Financial Performance

The chart below illustrates the trends in the financial health of Certara, Inc. over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.


Annual
Quarterly

0.0

Valuation

The Valuation section provides an overview of how Certara, Inc. is priced in the market compared to other companies in the Biotechnology industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.


PS Ratio

This chart shows the Price-to-Sales (P/S) ratio for CERT relative to other companies in the Biotechnology industry. Currently, CERT has a P/S ratio of 2.2. This P/S ratio is low compared to the industry average. It may indicate that the stock is undervalued relative to its revenue, or that the market expects slower growth or lower margins.

PB Ratio

The chart illustrates the Price-to-Book (P/B) ratio for CERT in comparison with other companies in the Biotechnology industry. Currently, CERT has a P/B value of 0.9. This P/B ratio is low compared to industry peers. It might indicate the stock is undervalued or that the company’s assets are not expected to generate strong returns.

Income Statement



TTM
Revenue

Total Revenue

Cost Of Revenue

Gross Profit

Operating Expenses

Selling, General & Admin Expenses

R&D Expenses

Depreciation And Amortization

Total Operating Expenses

Income

Income Before Tax

Operating Income

EBITDA

EBIT

Earnings From Continuing Operations

Net Income

Income Tax Expense

Other Non-Operating Income (Expenses)

Extraordinary Items

Discontinued Operations

Effect Of Accounting Charges

Non Recurring

Minority Interest

Other Items

Interest Income

Interest Expense

Net Interest Income

Values in undefined except per share items